Correlation Between BeiGene and Foghorn Therapeutics
Can any of the company-specific risk be diversified away by investing in both BeiGene and Foghorn Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BeiGene and Foghorn Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BeiGene and Foghorn Therapeutics, you can compare the effects of market volatilities on BeiGene and Foghorn Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BeiGene with a short position of Foghorn Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of BeiGene and Foghorn Therapeutics.
Diversification Opportunities for BeiGene and Foghorn Therapeutics
-0.29 | Correlation Coefficient |
Very good diversification
The 3 months correlation between BeiGene and Foghorn is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding BeiGene and Foghorn Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Foghorn Therapeutics and BeiGene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BeiGene are associated (or correlated) with Foghorn Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Foghorn Therapeutics has no effect on the direction of BeiGene i.e., BeiGene and Foghorn Therapeutics go up and down completely randomly.
Pair Corralation between BeiGene and Foghorn Therapeutics
Given the investment horizon of 90 days BeiGene is expected to generate 5.1 times less return on investment than Foghorn Therapeutics. But when comparing it to its historical volatility, BeiGene is 2.31 times less risky than Foghorn Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Foghorn Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 810.00 in Foghorn Therapeutics on September 1, 2024 and sell it today you would lose (11.00) from holding Foghorn Therapeutics or give up 1.36% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
BeiGene vs. Foghorn Therapeutics
Performance |
Timeline |
BeiGene |
Foghorn Therapeutics |
BeiGene and Foghorn Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with BeiGene and Foghorn Therapeutics
The main advantage of trading using opposite BeiGene and Foghorn Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BeiGene position performs unexpectedly, Foghorn Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Foghorn Therapeutics will offset losses from the drop in Foghorn Therapeutics' long position.BeiGene vs. Cue Biopharma | BeiGene vs. Tff Pharmaceuticals | BeiGene vs. Lantern Pharma | BeiGene vs. Eliem Therapeutics |
Foghorn Therapeutics vs. C4 Therapeutics | Foghorn Therapeutics vs. Prelude Therapeutics | Foghorn Therapeutics vs. Rezolute | Foghorn Therapeutics vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |